MX2015012459A - Polimorfos y sales de un compuesto. - Google Patents
Polimorfos y sales de un compuesto.Info
- Publication number
- MX2015012459A MX2015012459A MX2015012459A MX2015012459A MX2015012459A MX 2015012459 A MX2015012459 A MX 2015012459A MX 2015012459 A MX2015012459 A MX 2015012459A MX 2015012459 A MX2015012459 A MX 2015012459A MX 2015012459 A MX2015012459 A MX 2015012459A
- Authority
- MX
- Mexico
- Prior art keywords
- salts
- disorders
- polymorphic forms
- crystalline polymorphic
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
Abstract
Se describen nuevas formas polimórficas cristalinas de la 4-(4(imidazol [1,2-b]piridazin-2-ilmetoxi)fenil)-2,2-dimetil-5-(pi ridin-4-il)furan-3(2H)-ona y sus sales, métodos para preparar las formas polimórficas cristalinas y sus sales, y métodos para tratar trastornos del sistema nervioso central, trastornos de la alimentación, obesidad, juego compulsivo, trastornos sexuales, narcolepsia, trastornos del sueño, diabetes, síndrome metabólico, esquizofrenia, dolencias de tipo esquizoafectivo, enfermedad de Huntington, trastornos bipolares, dolencias distónicas y discinensia tardía, o para su uso en el tratamiento del abandono del tabaquismo en un paciente usando las formas polimórficas cristalinas y sus sales.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361785692P | 2013-03-14 | 2013-03-14 | |
| PCT/US2014/026988 WO2014152135A1 (en) | 2013-03-14 | 2014-03-14 | Polymorphs and salts of a compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015012459A true MX2015012459A (es) | 2016-05-09 |
Family
ID=51581126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015012459A MX2015012459A (es) | 2013-03-14 | 2014-03-14 | Polimorfos y sales de un compuesto. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20160002250A1 (es) |
| EP (1) | EP2970245A4 (es) |
| JP (1) | JP2016513676A (es) |
| KR (1) | KR20150126884A (es) |
| CN (1) | CN105358557A (es) |
| AU (1) | AU2014240130A1 (es) |
| BR (1) | BR112015022806A2 (es) |
| CA (1) | CA2906073A1 (es) |
| HK (1) | HK1220458A1 (es) |
| IL (1) | IL241495A0 (es) |
| MX (1) | MX2015012459A (es) |
| TW (1) | TW201512201A (es) |
| WO (1) | WO2014152135A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI634114B (zh) * | 2013-05-08 | 2018-09-01 | 永恒生物科技公司 | 作為激酶抑制劑之呋喃酮化合物 |
| JP2018535969A (ja) * | 2015-11-04 | 2018-12-06 | オメロス コーポレーション | Ｐｄｅ１０阻害剤の固体状態形態 |
| KR20200141985A (ko) * | 2018-02-07 | 2020-12-21 | 리아타 파마슈티컬즈, 아이엔씨. | 노보비오신 유사체 및 프롤린의 공-결정 형태 |
| CN113125500B (zh) * | 2021-04-21 | 2022-04-15 | 大连理工大学 | 一种跨尺度的含水合物多孔介质热导率的计算方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE256128T1 (de) * | 1998-10-21 | 2003-12-15 | Takeda Chemical Industries Ltd | Kondensierte pyridazinderivate, verfahren zu ihrer herstellung und ihre anwendung |
| US7927613B2 (en) * | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| JP5658664B2 (ja) * | 2008-06-25 | 2015-01-28 | フォルム ファーマシューティカルズ、インコーポレイテッド | １，２−二置換複素環式化合物 |
| PL2617420T3 (pl) * | 2009-05-07 | 2016-04-29 | Forum Pharmaceuticals Inc | Heterocykliczne związki fenoksymetylu |
| KR101774035B1 (ko) * | 2009-10-30 | 2017-09-01 | 얀센 파마슈티카 엔.브이. | 이미다조［１，２―ｂ］피리다진 유도체 및 ＰＤＥ１０ 저해제로서의 그의 용도 |
| US20130005710A1 (en) * | 2009-11-18 | 2013-01-03 | Tetsuya Tsukamoto | Aminopyridine derivative |
| TW201307334A (zh) * | 2010-12-17 | 2013-02-16 | Cocrystal Discovery Inc | Ｃ型肝炎病毒聚合酶抑制劑 |
-
2014
- 2014-03-13 TW TW103109023A patent/TW201512201A/zh unknown
- 2014-03-14 JP JP2016502302A patent/JP2016513676A/ja active Pending
- 2014-03-14 AU AU2014240130A patent/AU2014240130A1/en not_active Abandoned
- 2014-03-14 MX MX2015012459A patent/MX2015012459A/es unknown
- 2014-03-14 CA CA2906073A patent/CA2906073A1/en not_active Abandoned
- 2014-03-14 BR BR112015022806A patent/BR112015022806A2/pt not_active IP Right Cessation
- 2014-03-14 KR KR1020157026952A patent/KR20150126884A/ko not_active Application Discontinuation
- 2014-03-14 EP EP14767356.0A patent/EP2970245A4/en not_active Withdrawn
- 2014-03-14 CN CN201480027251.7A patent/CN105358557A/zh active Pending
- 2014-03-14 WO PCT/US2014/026988 patent/WO2014152135A1/en active Search and Examination
-
2015
- 2015-09-10 IL IL241495A patent/IL241495A0/en unknown
- 2015-09-11 US US14/851,250 patent/US20160002250A1/en not_active Abandoned
-
2016
- 2016-07-19 HK HK16108550.7A patent/HK1220458A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2970245A1 (en) | 2016-01-20 |
| WO2014152135A1 (en) | 2014-09-25 |
| IL241495A0 (en) | 2015-11-30 |
| HK1220458A1 (zh) | 2017-05-05 |
| TW201512201A (zh) | 2015-04-01 |
| EP2970245A4 (en) | 2016-10-19 |
| KR20150126884A (ko) | 2015-11-13 |
| JP2016513676A (ja) | 2016-05-16 |
| CN105358557A (zh) | 2016-02-24 |
| US20160002250A1 (en) | 2016-01-07 |
| BR112015022806A2 (pt) | 2017-07-18 |
| CA2906073A1 (en) | 2014-09-25 |
| AU2014240130A1 (en) | 2015-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017500166A1 (en) | 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors | |
| PH12017501661A1 (en) | 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof | |
| EA201891374A1 (ru) | Замещенные 2-фенил-3-(пиперазинметил)имидазопиридины и их применение | |
| NZ711424A (en) | Pyridine derivatives as soft rock inhibitors | |
| EA201391029A1 (ru) | Производные оксазина и их применение при лечении неврологических нарушений | |
| TN2012000249A1 (en) | Pyrazine derivatives and their use in the treatment of neurological disorders | |
| MX2015002511A (es) | Compuestos de dihidropirimidina y su aplicacion en productos farmaceuticos. | |
| EA201591051A1 (ru) | Ингибиторы erk и варианты их применения | |
| NZ627586A (en) | Pyridone derivatives | |
| MX2015012459A (es) | Polimorfos y sales de un compuesto. | |
| MX343706B (es) | Derivados heterocíclicos novedosos. | |
| NZ601483A (en) | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| PH12015500376B1 (en) | Novel bicyclic pyridinones | |
| EA201491028A1 (ru) | Способ получения замещенных 5-фтор-1н-пиразолопиридинов | |
| IL216967A0 (en) | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases | |
| MX2013008056A (es) | 1,4-oxazepinas como inhibidores de beta-secretasa 1 (bace1) y/o beta-secretasa 2 (bace2). | |
| WO2014153203A3 (en) | Alkyl-amine harmine derivatives for promoting bone growth | |
| PH12019500497A1 (en) | Heteroaryl carboxamide compounds as inhibitors of ripk2 | |
| MX2016008536A (es) | Derivados de fluoro-naftilo. | |
| WO2012099952A3 (en) | Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia | |
| RU2011141760A (ru) | Производные n-[(6-азабицикло[3.2.1]окт-5-ил)-арилметил]-гетеробензамида, их получение и их применение в терапии | |
| IN2014DN10680A (es) | ||
| NZ610853A (en) | Phenylketone carboxylate compounds and pharmaceutical uses thereof | |
| MX2012006287A (es) | Activadores de azaindol glucocinasa. | |
| CY1110087T1 (el) | Μεθοδοι παρασκευης ενωσεων που περιεχουν πυρραζολιο |